NJ nixes stem cell research

New Jersey voters nixed Governor Jon Corzine's proposal to borrow $450 million over 10 years to fund linkurl:stem cell research;http://www.the-scientist.com/news/home/53836/ yesterday (November 6). Voters defeated the measure by a 53-47 margin. Corzine introduced the proposal in July, and supporters argued it would serve as an economic boon to the state. California, New York, and Massachusetts have already devoted extensive funds to stem cell research. According to the New York Times, t

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
New Jersey voters nixed Governor Jon Corzine's proposal to borrow $450 million over 10 years to fund linkurl:stem cell research;http://www.the-scientist.com/news/home/53836/ yesterday (November 6). Voters defeated the measure by a 53-47 margin. Corzine introduced the proposal in July, and supporters argued it would serve as an economic boon to the state. California, New York, and Massachusetts have already devoted extensive funds to stem cell research. According to the New York Times, this was the linkurl:first time in 17 years;http://www.nytimes.com/2007/11/07/nyregion/07jersey.html?_r=1&oref=slogin that New Jersey voters rejected a statewide ballot question. Critics of the bill said the measure was too expensive, and opponents (including conservatives and anti-abortionists) campaigned against it.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies